NeuBase Therapeutics Inc (NBSE)
0.405
-0.01
(-1.72%)
USD |
NASDAQ |
May 03, 16:00
0.376
-0.03
(-7.16%)
After-Hours: 20:00
NeuBase Therapeutics Cash from Investing (TTM): -0.0548M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -0.0548M |
June 30, 2023 | -0.0836M |
March 31, 2023 | -0.2542M |
December 31, 2022 | -0.3977M |
September 30, 2022 | -0.4717M |
June 30, 2022 | -0.7946M |
March 31, 2022 | -2.418M |
December 31, 2021 | -2.479M |
September 30, 2021 | -2.564M |
June 30, 2021 | -2.566M |
March 31, 2021 | -0.9728M |
December 31, 2020 | -0.857M |
September 30, 2020 | -0.7168M |
June 30, 2020 | -1.044M |
March 31, 2020 | -0.8431M |
December 31, 2019 | -0.7536M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | 0.0885M |
Date | Value |
---|---|
June 30, 2017 | 0.0822M |
March 31, 2017 | -0.0072M |
December 31, 2016 | -0.0088M |
September 30, 2016 | -0.0145M |
June 30, 2016 | -0.0154M |
March 31, 2016 | -0.1102M |
December 31, 2015 | -0.2955M |
September 30, 2015 | -0.285M |
June 30, 2015 | -0.2977M |
March 31, 2015 | -3.702M |
December 31, 2014 | -3.515M |
September 30, 2014 | -3.515M |
June 30, 2014 | -3.50M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.0334M |
June 30, 2012 | -0.0334M |
March 31, 2012 | -0.0334M |
December 31, 2011 | 0.0371M |
September 30, 2011 | 0.0705M |
June 30, 2011 | 0.0455M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.566M
Minimum
Jun 2021
-0.0548M
Maximum
Sep 2023
-1.079M
Average
-0.8188M
Median
Cash from Investing (TTM) Benchmarks
Ampio Pharmaceuticals Inc | -- |
Stoke Therapeutics Inc | 105.95M |
ABVC BioPharma Inc | -0.3602M |
MAIA Biotechnology Inc | -- |
Aprea Therapeutics Inc | -- |